Cointime

EpiVax

company

About

EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.

  • 11 - 50

Highlights

Total Funding Amount
$4.21M
Funding Rounds
7
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$300K
Industries
Analytics,Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 1998
Number Of Employee
11 - 50
Operating Status
Active

EpiVax is an immunology company and has developed comprehensive analytical capabilities in the field of computational immunology.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
7
$4.21M
EpiVax has raised a total of $4.21M in funding over 2 rounds. Their latest funding was raised on Sep 12, 2016 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 12, 2016 Grant $600K 1 National Institutes of Health — Detail
Sep 5, 2012 Grant $300K 1 National Institutes of Health — Detail
Apr 9, 2012 Grant $1.50M 1 — — Detail
Jan 25, 2011 Grant $458K 1 — — Detail
Nov 26, 2008 Grant $390K 1 — — Detail
Show More

Investors

Number of Lead Investors
Number of Investors
2
1
EpiVax is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
Cointime
เนื้อหา
บริษัท